In Burlington, Massachusetts on July 22, 2026, Fractyl Health, Inc. (Nasdaq: GUTS), a clinical-stage company developing innovative treatments for obesity and type 2 diabetes, revealed that Dr. Harith Rajagopalan, the Co-Founder and CEO, will engage in upcoming investor conferences. Fractyl is dedicated to pioneering new methods for addressing obesity and T2D.